Limited Submission Funding Announcements

These are research funding opportunities where there is a limit to the number of applications that can be submitted. Faculty interested in applying are asked to provide a preliminary proposal for an internal selection committee. Please see below the current available funding opportunities and their internal submission deadlines.

NIH - Biomedical Research Facilities │ December 16

The National Institutes of Health (NIH), Office of Research Infrastructure Programs (ORIP) Biomedical Research Facilities (C06 Clinical Trial Not Allowed) program is accepting applications from eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications from both research-intensive institutions and Institutions of Emerging Excellence (IEE) in biomedical research, both highly resourced and low-resourced institutions, from all geographic regions in the nation are strongly encouraged.

NIH recognizes the importance of all institutions of higher learning in contributing to the nation’s research capacity. The goal of this funding opportunity is to modernize biomedical research infrastructure to strengthen biomedical research programs. Each project is expected to provide long-term improvements to the institutional research infrastructure. Intended projects are the construction or modernization of core facilities and the development of other shared research infrastructure serving an institution-wide research community with broad impact on biomedical research.

Funding Information: The budget is $3M to $8M for a five-year project.

Eligibility Restrictions:

Only ONE application per organization as defined by NIH IPF number is allowed.
Only one active BRF C06 is allowed at a time with respect to last three fiscal years. Grantees under PAR-20-086, PAR-21-139, PAR-22-088, or PAR-23-045 (last three years) are not eligible.
25% of total funds are set aside for institutions of emerging excellence (IEEs).
Resubmission (A1) applications are NOT allowed. Unsuccessful prior applications must submit as a new application (A0) and not include an introduction or discussion of previous submission.

One major difference is the 10-year term of the Notice of Federal Interest (NFI) requirement instead of 20-year term.

Internal Process: Interested BU investigators should submit the following materials as a PDF file to awtaylor@bu.edu by Monday, Dec. 16, 2024.

A brief statement (up to 2 pages) by the candidate describing the proposed project;
A letter of support from the departmental chair or Dean;
A brief budget outline for the proposed project;
Up-to-date CV or NIH biosketch.

Deadlines: Internal Due Date: Monday, Dec. 16, 2024 ⃒ NIH Application Due Date: Jan. 27, 2025

In requesting to be considered for this limited submission funding opportunity, you are making a commitment, if selected, to submit your proposal to the sponsor in a timely manner and to Sponsored Programs in accordance with the Proposal Submission Policy.

NIH - Biomedical Research Shared Instrumentation Grants │ March 28

International Balzan Prize 2025 │ February 7

The International Balzan Prize Foundation’s aim is to promote culture, the sciences, and the most meritorious initiatives in the cause of humanity, peace, and fraternity among peoples throughout the world. The four Balzan Prizes are awarded to scholars, artists, and scientists who have distinguished themselves in their fields on an international level.

The subject areas in which the awards are granted are rotated, and this special characteristic of the Balzan Prize ensures the promotion and recognition of new or emerging fields of study or research that may have been overlooked by other international awards.

Nominees in the following fields are eligible for this year’s nomination:

Social sciences and humanities:
- Classics: Athenian Democracy Revisited
- History of Contemporary Art
Physical, mathematical, natural sciences, and medicine:
- Atoms and Ultra-Precise Measurement of Time
- Gene and Gene-Modified Cell Therapy

FUNDING INFORMATION: 750,000 Swiss francs will be awarded to each of the Balzan Prize Winners. As of 2001, the Balzan designated that half of the prize sum will be awarded to the winner while the other half will be earmarked to support the winner’s research projects involving young researchers or research groups. This future research proposal will be subject to the approval of the General Prize Committee.

ELIGIBILITY RESTRICTIONS: BU can nominate more than one candidate for each area. Prizes may be awarded to individuals or to working teams who have produced results jointly, and candidates do not have to be part of the institution of the individual making the nomination or of the same nationality.

INTERNAL SELECTION PROCESS: Interested investigators should submit the following materials via InfoReady Review by Friday, February 7, 2025

Reason for Nomination Statement (maximum 2 pages)
- Social science and humanities candidates should explain three of their unique aspects that have had the greatest scientific impact on the subject area of the award
- Sciences candidates should provide a description of their most significant results and their reasons for applying
Up-to-date CV that includes candidate’s present position, main academic activities, and nationality as well as:
- Social science and humanities: A list of 5 most significant publications; AND a complete and detailed bibliography, including translations
- Sciences: A list of their 10 most significant publications

As necessary, a faculty committee drawn from both campuses will review internal proposals and select the forwarded candidates.

DEADLINES:

Internal Materials Due: Friday, February 7, 2025, 11:59 pm ET
Sponsor Deadline: Saturday, March 15, 2025

If you have any questions about these funding opportunities contact us.

View the list of annually recurring limited submission opportunities sorted by anticipated internal deadline.